References
- SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
- JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
- GoldstrawPCrowleyJChanskyKThe iaslc lung cancer staging project: proposals for the revision of the tnm stage groupings in the forthcoming (seventh) edition of the tnm classification of malignant tumoursJ Thorac Oncol20072870671417762336
- SubramanianJGovindanRLung cancer in never smokers: a reviewJ Clin Oncol200725556157017290066
- BryantACerfolioRJDifferences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancerChest2007132118519217573517
- SpiraABeaneJShahVEffects of cigarette smoke on the human airway epithelial cell transcriptomeProc Natl Acad Sci U S A200410127101431014815210990
- PetersenSAninat-MeyerMSchlünsKGellertKDietelMPetersenIChromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lungBr J Cancer2000821657310638968
- NakachiKImaiKHayashiSKawajiriKPolymorphisms of the cyp1a1 and glutathione s-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese populationCancer Res19935313299429998319207
- VucicEAThuKLPikorLASmoking status impacts microrna mediated prognosis and lung adenocarcinoma biologyBMC Cancer201414177825342220
- KarlssonARingnérMLaussMGenomic and transcriptional alterations in lung adenocarcinoma in relation to smoking historyClin Cancer Res201420184912492425037737
- TroyanskayaOCantorMSherlockGMissing value estimation methods for DNA microarraysBioinformatics200117652052511395428
- RaoYLeeYJarjouraDA comparison of normalization techniques for microrna microarray dataStat Appl Genet Mol Biol20087122
- GautierLCopeLBolstadBMIrizarryRAAffy – analysis of affymetrix genechip data at the probe levelBioinformatics200420330731514960456
- SmythGKLimma: linear models for microarray dataGentlemanRCareyVDudoitSIrizarryRHuberWBioinformatics and computational biology solutions using r and bioconductorNew YorkSpringer2005397420
- Reiner-BenaimAFdr control by the bh procedure for two-sided correlated tests with implications to gene expression data analysisBiom J200749110712617342953
- PrasadTKGoelRKandasamyKHuman protein reference database – 2009 updateNucleic Acids Res200937suppl 1D767D77218988627
- ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
- RochatYCloseness centrality extended to unconnected graphs: the harmonic centrality indexASNA2009114
- MukherjeeSRifkinRSupport Vector Machine Classification Of Microarray DataAi Memo Massachusetts Institute of Technology20101514
- FriesRCComputational intelligence in biomedical engineering (Begg R, et al; 2008) [book reviews]IEEE Eng Med Biol Mag200952866
- JagerKJvan DijkPCZoccaliCDekkerFWThe analysis of survival data: the Kaplan–Meier methodKidney Int200874556056518596735
- SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Nat Acad Sci U S A2005102431554515550
- AlavanjaMCBiologic damage resulting from exposure to tobacco smoke and from radon: implication for preventive interventionsOncogene200221487365737512379879
- GovindanRLiDGriffithMGenomic landscape of non-small cell lung cancer in smokers and never-smokersCell201215061121113422980976
- OshimaTAkaikeMYoshiharaKOverexpression of epha4 gene and reduced expression of ephb2 gene correlates with liver metastasis in colorectal cancerIn J Oncol2008333573577
- SchlessingerJUllrichAGrowth factor signaling by receptor tyrosine kinasesNeuron1992933833911326293
- JubbAMZhongFBheddahSEphb2 is a prognostic factor in colorectal cancerClin Cancer Res200511145181518716033834
- NakamuraRKataokaHSatoNEpha2/efna1 expression in human gastric cancerCancer Sci2005961424715649254
- JingXSonokiTMiyajimaMEpha4-deleted microenvironment regulates cancer development of isografted 4t1 murine breast cancer cells via reduction of an igf1 signalCancer Med2016561214122726923183
- DuxburyMSItoHZinnerMJAshleySWWhangEEEpha2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinomaOncogene20042371448145614973554
- MiyazakiKInokuchiMTakagiYKatoKKojimaKSugiharaKEpha4 is a prognostic factor in gastric cancerBMC Clin Pathol20131311923738943
- SaintignyPPengSZhangLGlobal evaluation of eph receptors and ephrins in lung adenocarcinomas identifies epha4 as an inhibitor of cell migration and invasionMol Cancer Ther20121192021203222807579
- DaileyLAmbrosettiDMansukhaniABasilicoCMechanisms underlying differential responses to fgf signalingCytokine Growth Factor Rev200516223324715863038
- KuhnHKöpffCKonradJRiedelAGessnerCWirtzHInfluence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell linesLung Cancer200444216717415084381
- BehrensCLinHYLeeJJImmunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerClin Cancer Res200814196014602218829480
- LobodaANebozhynMKlinghofferRA gene expression signature of ras pathway dependence predicts response to pi3k and ras pathway inhibitors and expands the population of ras pathway activated tumorsBMC Med Genomics20103111120092628
- YoungALyonsJMillerALPhanVTAlarcónIRMcCormickFRas signaling and therapiesAdv Cancer Res200910211719595305
- SantarpiaLTargeting the mitogen-activated protein kinase ras-raf signaling pathway in cancer therapyPathol Int199646296676728905876
- AdjeiAABlocking oncogenic ras signaling for cancer therapyJ Nat Cancer Inst200193141062107411459867
- SantarpiaLLippmanSMEl-NaggarAKTargeting the mapk–ras–raf signaling pathway in cancer therapyExp Opin Ther Targets2012161103119
- MarekLWareKEFritzscheAFibroblast growth factor (fgf) and fgf receptor-mediated autocrine signaling in non-small-cell lung cancer cellsMol Pharmacol200975119620718849352
- SWHTYKPGHPredictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinibJ Clin Oncol200523112493250115710947
- PaoWChmieleckiJRational, biologically based treatment of egfr-mutant non-small-cell lung cancerNat Rev Cancer2010101176077420966921
- YanagawaNTamuraGOizumiHEndohMSadahiroMMotoyamaTInverse correlation between egfr mutation and fhit, rassf1a and runx3 methylation in lung adenocarcinoma: relation with smoking statusAnticancer Res201131311211121421508367
- PhillipsJJNovel therapeutic targets in the brain tumor microenvironmentOncotarget20123556857522643827
- IozzoRVSchaeferLProteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycansFEBS J2010277193864387520840584
- TheocharisADSkandalisSSNeillTInsights into the key roles of proteoglycans in breast cancer biology and translational medicineBiochim Biophys Acta20151855227630025829250